Role of blood–brain barrier dysfunction in the development of poststroke epilepsy
Epilepsia · 2024-09 · 65 (9) · 2519-2536
DOI: 10.1111/epi.18072 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Epilepsia, online erschienen am 05.08.2024. Verfasst von Wouter C Meijer und 1 weiteren Autor:innen. Beteiligte Einrichtung: Swammerdam Institute for Life Sciences, Center for Neuroscience, University of Amsterdam, Amsterdam, the Netherlands. Hauptthemen laut MEDLINE: Blood-Brain Barrier, Stroke, Epilepsy. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 156 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Stroke is a major contributor to mortality and morbidity worldwide and the most common cause of epilepsy in the elderly in high income nations. In recent years, it has become increasingly evident that both ischemic and hemorrhagic strokes induce dysfunction of the blood–brain barrier (BBB), and that this impairment can contribute to epileptogenesis. Nevertheless, studies directly comparing BBB dysfunction and poststroke epilepsy (PSE) are largely absent. Therefore, this review summarizes the role of BBB dysfunction in the development of PSE in animal models and clinical studies. There are multiple mechanisms whereby stroke induces BBB dysfunction, including increased transcytosis, tight junction dysfunction, spreading depolarizations, astrocyte and pericyte loss, reactive astrocytosis, angiogenesis, matrix metalloproteinase activation, neuroinflammation, adenosine triphosphate depletion, oxidative stress, and finally cell death. The degree to which these effects occur is dependent on the severity of the ischemia, whereby cell death is a more prominent mechanism of BBB disruption in regions of critical ischemia. BBB dysfunction can contribute to epileptogenesis by increasing the risk of hemorrhagic transformation, increasing stroke size and the amount of cerebral vasogenic edema, extravasation of excitatory compounds, and increasing neuroinflammation. Furthermore, albumin extravasation after BBB dysfunction contributes to epileptogenesis primarily via increased transforming growth factor β signaling. Finally, seizures themselves induce BBB dysfunction, thereby contributing to epileptogenesis in a cyclical manner. In repairing this BBB dysfunction, pericyte migration via platelet‐derived growth factor β signaling is indispensable and required for reconstruction of the BBB, whereby astrocytes also play a role. Although animal stroke models have their limitations, they provide valuable insights into the development of potential therapeutics designed to restore the BBB after stroke, with the ultimate goal of improving outcomes and minimizing the occurrence of PSE. In pursuit of this goal, rapamycin, statins, losartan, semaglutide, and metformin show promise, whereby modulation of pericyte migration could also be beneficial.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Swammerdam Institute for Life Sciences, Center for Neuroscience, University of Amsterdam, Amsterdam, the Netherlands.
ORCID-Profile: Wouter C Meijer, Jan A Gorter
Zitieren
APA
Meijer, W. C., & Gorter, J. A. (2024). Role of blood–brain barrier dysfunction in the development of poststroke epilepsy. Epilepsia, 65(9), 2519-2536. https://doi.org/10.1111/epi.18072
Vancouver
Meijer WC, Gorter JA. Role of blood–brain barrier dysfunction in the development of poststroke epilepsy. Epilepsia. 2024;65(9):2519-2536. doi:10.1111/epi.18072
BibTeX
@article{Meijer2024,
author = {Meijer, Wouter C and Gorter, Jan A},
title = {Role of blood–brain barrier dysfunction in the development of poststroke epilepsy},
journal = {Epilepsia},
year = {2024},
volume = {65},
number = {9},
pages = {2519--2536},
doi = {10.1111/epi.18072}
}
EUVIMED